Search research articles
Contact Us
Filters
Showing results (271-280 of 280) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 280 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2025
Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2021
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
Sue S Yom, Pedro Torres-Saavedra, Jimmy J Caudell, et al.
Molecular and Cellular Biochemistry
|
September 16, 2017
Unprecedented anticancer activities of organorhenium sulfonato and carboxylato complexes against hormone-dependent MCF-7 and hormone-independent triple-negative MDA-MB-231 breast cancer cells
Paul T Wilder, David J Weber, Angela Winstead, et al.
Circulation Research
|
September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)
Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 23, 2021
Genome-wide analysis in 756,646 individuals provides first genetic evidence that <i>ACE2</i> expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease
J E Horowitz, J A Kosmicki, A Damask, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 3, 2021
A catalog of associations between rare coding variants and COVID-19 outcomes
J A Kosmicki, J E Horowitz, N Banerjee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Aline Talhouk, Joshy George, Chen Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancer
J Millstein, T Budden, E L Goode, et al.
Nature Genetics
|
March 28, 2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Catherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 280) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 280 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2025
Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2021
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
Sue S Yom, Pedro Torres-Saavedra, Jimmy J Caudell, et al.
Molecular and Cellular Biochemistry
|
September 16, 2017
Unprecedented anticancer activities of organorhenium sulfonato and carboxylato complexes against hormone-dependent MCF-7 and hormone-independent triple-negative MDA-MB-231 breast cancer cells
Paul T Wilder, David J Weber, Angela Winstead, et al.
Circulation Research
|
September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)
Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 23, 2021
Genome-wide analysis in 756,646 individuals provides first genetic evidence that <i>ACE2</i> expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease
J E Horowitz, J A Kosmicki, A Damask, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 3, 2021
A catalog of associations between rare coding variants and COVID-19 outcomes
J A Kosmicki, J E Horowitz, N Banerjee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Aline Talhouk, Joshy George, Chen Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancer
J Millstein, T Budden, E L Goode, et al.
Nature Genetics
|
March 28, 2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Catherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, et al.
Page
of 28